Premium
ABERRANT HYPEREDITING OF MYELOMA TRANSCRIPTOME BY ADAR1 CONFERS ONCOGENICITY AND IS A MARKER OF POOR PROGNOSIS
Author(s) -
Teoh P.,
An O.,
Chung T.,
Chooi J.,
Toh S.,
Fan S.,
Wang W.,
Koh B.,
Fullwood M.,
Ooi M.,
Mel S.,
Soekojo C.,
Chen P.,
Ng S.,
Yang H.,
Chng W.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.237_2631
Subject(s) - transcriptome , biology , rna , microarray , rna editing , disease , gene , gene expression , chromosomal translocation , cancer research , genetics , pathology , medicine